TITLE

Medical conditions underlying retinal vein occlusion in patients with glaucoma or ocular hypertension

AUTHOR(S)
Cole, M D; Dodson, P M; Hendeles, S
PUB. DATE
September 1989
SOURCE
British Journal of Ophthalmology;Sep1989, Vol. 73 Issue 9, p693
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66011584

 

Related Articles

  • Effects of latanoprostene bunod on IOP explored in crossover study. Dalton, Michelle; Liu, John H. K. // Ophthalmology Times;9/15/2014, Vol. 39 Issue 17, p38 

    The article offers information on a study which assessed the impact of latanoprostene bunod on patients with intraocular pressure (IOP). Topics covered include the effectiveness of the treatment as well as response of patients with ocular hypertension and glaucoma to the treatment. Also...

  • Ocular and systemic causes of retinopathy in patients without diabetes mellitus. Venkatramani, Jayant; Mitchell, Paul // BMJ: British Medical Journal (International Edition);3/13/2004, Vol. 328 Issue 7440, p625 

    Presents a clinical review of ocular and systemic causes of retinopathy in patients without diabetes mellitus. Statement that ocular conditions associated with retinopathy in non-diabetic patients include retinal vein occlusions, retinal telangiectasia and retinal macroaneurysms; Statement that...

  • Four steps to approaching vein occlusion. Charters, Lynda // Ophthalmology Times;Mar2015, Vol. 40 Issue 4, p15 

    The article suggests ways on how to treat patients with retinal vein occlusions, according to ophthalmologist-in-chief Dr. Julia A. Haller. Topics covered include the need to evaluate patients for diabetes, glaucoma and hypertension, the impact of ocular evaluation on treatment decisions in...

  • Which Came First: OAG or RVO?  // Review of Optometry;Oct2013, Vol. 150 Issue 10, p103 

    A case study is presented of a seventy seven-year-old Hispanic female presented for an evaluation of reduced vision in her left eye. As stated, her ocular history was remarkable for a central retinal vein occlusion (CRVO) in her left eye and possible glaucoma in both eyes along with...

  • Therapeutic Benefit of Radial Optic Neurotomy in a Rat Model of Glaucoma. Belforte, Nicol�s; Sande, Pablo H.; Zaval�a, Nuria de; Dorfman, Dami�n; Rosenstein, Ruth E. // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Radial optic neurotomy (RON) has been proposed as a surgical treatment to alleviate the neurovascular compression and to improve the venous outflow in patients with central retinal vein occlusion. Glaucoma is characterized by specific visual field defects due to the loss of retinal ganglion...

  • Therapeutic Benefit of Radial Optic Neurotomy in a Rat Model of Glaucoma. Belforte, Nicolás; Sande, Pablo H.; Zavalía, Nuria de; Dorfman, Damián; Rosenstein, Ruth E. // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Radial optic neurotomy (RON) has been proposed as a surgical treatment to alleviate the neurovascular compression and to improve the venous outflow in patients with central retinal vein occlusion. Glaucoma is characterized by specific visual field defects due to the loss of retinal ganglion...

  • Triamcinolone.  // Reactions Weekly;5/21/2011, Issue 1352, p36 

    The article describes two cases of patients who developed ocular hypertension after intravitreal administration of triamcinolone acetonide for macular oedema secondary to branch retinal vein occlusion (BRVO).

  • Treatment of ME secondary to RVO. Thomas, Felicity // Ophthalmology Times Europe;Jan/Feb2015, Vol. 11 Issue 1, p30 

    The article discusses a retrospective study conducted by doctor Sylvia Nghiem-Buffet which analyzes the treatment of patients with macular oedema (ME) secondary to retinal vein occlusion (RVO). The study enrolled 65 patients with glaucoma or ocular hypertension who were treated with...

  • Risk Factors for Central and Branch Retinal Vein Occlusion: A Meta-Analysis of Published Clinical Data. Kolar, Petr // Journal of Ophthalmology;2014, p1 

    Retinal vein occlusion (RVO) is a major cause of vision loss. Of the two main types of RVO, branch retinal vein occlusion (BRVO) is 4 to 6 times more prevalent than central retinal vein occlusion (CRVO). A basic risk factor for RVO is advancing age. Further risk factors include systemic...

  • Peginterferon.  // Reactions Weekly;8/25/2012, Issue 1416, p35 

    The article describes the case of a 50-year-old man who developed central retinal vein occlusion (CRVO) and central retinal artery occlusion (CRAO) and neovascular glaucoma while under peginterferon treatment regimen.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics